scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10585-011-9431-7 |
P8608 | Fatcat ID | release_i3iimlg2u5da3bhfw2vyve2dl4 |
P698 | PubMed publication ID | 22045227 |
P2093 | author name string | Seong-Hoon Park | |
Do-Sim Park | |||
Eun-Taik Jeong | |||
Hak-Ryul Kim | |||
Ki-Eun Hwang | |||
Byoung-Ryun Kim | |||
Hyeok Shim | |||
Keum-Ha Choi | |||
Seok-Don Park | |||
P2860 | cites work | A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma | Q24322614 |
Revisions in the International System for Staging Lung Cancer | Q28241070 | ||
Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions | Q28301762 | ||
Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy | Q32160181 | ||
Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions | Q36619898 | ||
Survivin: a promising tumor biomarker | Q36726840 | ||
Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis | Q36851036 | ||
Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis. | Q37006185 | ||
Malignant effusions: Diagnostic evaluation and therapeutic strategy | Q40124844 | ||
Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma | Q44053480 | ||
Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer | Q44167393 | ||
The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer | Q45027131 | ||
Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. | Q45122877 | ||
Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study. | Q46871645 | ||
IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes. | Q52009124 | ||
Quantitative detection of survivin in malignant pleural effusion for the diagnosis and prognosis of lung cancer. | Q53450743 | ||
Survivin gene expression in early-stage non-small cell lung cancer. | Q54762265 | ||
Survivin, cancer networks and pathway-directed drug discovery. | Q55046676 | ||
Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions | Q59274557 | ||
Emmprin and Survivin Predict Response and Survival following Cisplatin-Containing Chemotherapy in Patients with Advanced Bladder Cancer | Q59468814 | ||
The treatment of malignant pleural effusions | Q68680949 | ||
Diagnostic principles in pleural disease | Q73094101 | ||
Improving tumor cell detection in pleural effusions by interphase cytogenetics | Q73887318 | ||
Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas | Q74530673 | ||
The inhibitors of apoptosis (IAPs) and their emerging role in cancer | Q77900361 | ||
Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer | Q80945456 | ||
Expression of survivin and of antigen detected by a novel monoclonal antibody, T332, is associated with outcome of diffuse large B-cell lymphoma and its subtypes | Q81826623 | ||
Serum levels of HMGB1, survivin, and VEGF in patients with advanced non-small cell lung cancer during chemotherapy | Q84133464 | ||
P433 | issue | 2 | |
P304 | page(s) | 83-89 | |
P577 | publication date | 2011-11-02 | |
P1433 | published in | Clinical & Experimental Metastasis | Q13470030 |
P1476 | title | Elevated survivin is associated with a poor response to chemotherapy and reduced survival in lung cancer with malignant pleural effusions. | |
P478 | volume | 29 |
Q39282601 | BIRC5 expression is a poor prognostic marker in Ewing sarcoma |
Q47679320 | Detection of survivin, carcinoembryonic antigen and ErbB2 level in oral squamous cell carcinoma patients |
Q35080864 | Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions |
Q34371434 | Diagnostic value of survivin for malignant pleural effusion: a clinical study and meta-analysis. |
Q39253762 | Sodium valproate potentiates staurosporine-induced apoptosis in neuroblastoma cells via Akt/survivin independently of HDAC inhibition. |
Search more.